COMMODORE CAPITAL LP holdings history

Add to watchlist

83 is the total number of securities COMMODORE CAPITAL LP has owned. The longest COMMODORE CAPITAL LP has owned a single stock is 12 quarters.

COMMODORE CAPITAL LP historical holdings. Includes current and past holdings.
Period Weighting Quarter
TickerNameLongestShortestMin.Avg.Max.FirstLatest↓ Count
XENE XENON PHARMACEUTICALS INC12122.12%6.78%10.26%Q4 2020Q3 202312
COGT COGENT BIOSCIENCES INC12123.86%6.37%10.36%Q4 2020Q3 202312
VRDN VIRIDIAN THERAPEUTICS INC11111.19%4.84%8.89%Q1 2021Q3 202311
CBAY CYMABAY THERAPEUTICS INC11112.49%4.10%5.42%Q4 2020Q2 202311
KURA KURA ONCOLOGY INC741.49%3.36%7.08%Q4 2020Q3 202311
CLDX CELLDEX THERAPEUTICS I...741.84%2.89%3.77%Q4 2020Q3 202311
ACRS ACLARIS THERAPEUTICS INC10100.78%7.20%10.39%Q4 2020Q1 202310
CELC CELCUITY INC10101.49%2.82%7.28%Q2 2021Q3 202310
KALV KALVISTA PHARMACEUTICA...10100.32%0.99%2.20%Q1 2021Q2 202310
MRUS MERUS N V994.16%9.51%12.52%Q3 2021Q3 20239
BLSA BCLS ACQUISITION CORP880.40%0.77%1.51%Q4 2020Q3 20228
ISEE IVERIC BIO INC773.84%7.19%12.46%Q4 2020Q2 20227
STSA SATSUMA PHARMACEUTICAL...773.15%4.43%7.61%Q1 2021Q3 20227
VTGN VISTAGEN THERAPEUTICS INC772.43%3.27%3.82%Q4 2020Q2 20227
SNDX SYNDAX PHARMACEUTICALS...521.62%2.62%3.99%Q4 2020Q3 20237
IVA INVENTIVA SA770.21%1.04%1.82%Q4 2020Q2 20227
BLU BELLUS HEALTH INC NEW665.83%7.62%8.75%Q4 2021Q1 20236
CYTK CYTOKINETICS INC664.86%6.87%7.51%Q2 2021Q3 20226
CCCC C4 THERAPEUTICS INC662.61%5.66%8.67%Q4 2020Q1 20226
PTGX PROTAGONIST THERAPEUTI...661.76%3.53%6.38%Q4 2020Q1 20226
DAWN DAY ONE BIOPHARMACEUTI...660.99%1.86%2.80%Q2 2022Q3 20236
MREO MEREO BIOPHARMA GROUP PLC660.49%1.85%3.61%Q4 2020Q1 20226
GNCA GENOCEA BIOSCIENCES INC660.83%1.84%3.10%Q4 2020Q1 20226
PMVP PMV PHARMACEUTICALS INC660.58%1.59%4.18%Q4 2020Q1 20226
AKRO AKERO THERAPEUTICS INC553.34%5.05%8.79%Q3 2022Q3 20235
IMVT IMMUNOVANT INC411.92%3.00%4.49%Q4 2020Q3 20235
KRON KRONOS BIO INC550.94%2.68%4.85%Q4 2020Q4 20215
ARWR ARROWHEAD PHARMACEUTIC...552.15%2.39%2.82%Q2 2022Q2 20235
ALPN ALPINE IMMUNE SCIENCES...551.47%1.57%1.77%Q3 2022Q3 20235
DYN DYNE THERAPEUTICS INC550.66%1.54%2.66%Q1 2021Q1 20225
THIRD HARMONIC BIO INC550.54%1.24%3.11%Q3 2022Q3 20235
NUVALENT INC444.10%4.57%5.45%Q4 2022Q3 20234
PCVX VAXCYTE INC441.14%3.66%6.56%Q4 2022Q3 20234
TCDA TRICIDA INC442.76%3.36%4.15%Q4 2021Q3 20224
CABA CABALETTA BIO INC441.41%2.91%4.49%Q4 2022Q3 20234
KPTI KARYOPHARM THERAPEUTIC...440.99%2.60%5.86%Q1 2022Q4 20224
MRSN MERSANA THERAPEUTICS INC310.33%1.86%2.77%Q4 2020Q3 20234
ALLK ALLAKOS INC311.29%1.71%2.08%Q4 2021Q1 20234
TENAYA THERAPEUTICS INC440.43%1.71%2.80%Q3 2021Q2 20224
SBTX SILVERBACK THERAPEUTIC...440.26%1.36%2.45%Q4 2020Q3 20214
IMUX IMMUNIC INC440.38%0.94%2.25%Q1 2022Q4 20224
RZLT REZOLUTE INC440.26%0.50%0.83%Q2 2022Q1 20234
DBVT DBV TECHNOLOGIES S A440.02%0.02%0.02%Q4 2022Q3 20234
VERA VERA THERAPEUTICS INC333.34%7.30%9.83%Q1 2023Q3 20233
AMAM AMBRX BIOPHARMA INC334.73%5.71%6.52%Q1 2023Q3 20233
ENLIVEN THERAPEUTICS INC334.63%5.26%5.77%Q1 2023Q3 20233
CNST CONSTELLATION PHARMCET...333.43%5.09%6.64%Q4 2020Q2 20213
ADVM ADVERUM BIOTECHNOLOGIE...330.55%1.36%1.79%Q1 2023Q3 20233
ENTA ENANTA PHARMACEUTICALS...330.86%1.26%1.57%Q3 2022Q1 20233
ABOS ACUMEN PHARMACEUTICALS...330.25%0.81%1.77%Q3 2022Q1 20233
FPRX FIVE PRIME THERAPEUTIC...224.92%5.17%5.42%Q4 2020Q1 20212
TRILLIUM THERAPEUTICS INC223.40%5.11%6.82%Q4 2020Q1 20212
RLMD RELMADA THERAPEUTICS INC222.27%2.69%3.11%Q4 2020Q1 20212
EPIX ESSA PHARMA INC222.05%2.43%2.81%Q1 2021Q2 20212
IDYA IDEAYA BIOSCIENCES INC222.05%2.25%2.44%Q2 2023Q3 20232
MGNX MACROGENICS INC220.59%2.14%3.69%Q1 2021Q2 20212
RXDX PROMETHEUS BIOSCIENCES...222.08%2.09%2.11%Q4 2022Q1 20232
RNA AVIDITY BIOSCIENCES INC221.38%1.68%1.98%Q4 2022Q1 20232
MCRB SERES THERAPEUTICS INC221.16%1.18%1.21%Q1 2021Q2 20212
LSAQ LIFESCI ACQUISITION II...220.40%0.49%0.58%Q4 2020Q1 20212
LRMR LARIMAR THERAPEUTICS INC220.39%0.43%0.47%Q3 2022Q4 20222
DRNA DICERNA PHARMACEUTICAL...116.87%6.87%6.87%Q3 2021Q3 20211
RYTM RHYTHM PHARMACEUTICALS...115.56%5.56%5.56%Q3 2023Q3 20231
SOLENO THERAPEUTICS INC113.06%3.06%3.06%Q3 2023Q3 20231
ARCELLX INC112.76%2.76%2.76%Q4 2022Q4 20221
IOVA IOVANCE BIOTHERAPEUTIC...112.36%2.36%2.36%Q3 2021Q3 20211
SURF SURFACE ONCOLOGY INC112.35%2.35%2.35%Q4 2020Q4 20201
FDMT 4D MOLECULAR THERAPEUT...112.00%2.00%2.00%Q4 2022Q4 20221
CRNX CRINETICS PHARMACEUTIC...111.74%1.74%1.74%Q3 2023Q3 20231
RVMD REVOLUTION MEDICINES INC111.64%1.64%1.64%Q3 2021Q3 20211
IMRA IMARA INC111.54%1.54%1.54%Q4 2022Q4 20221
ETNB 89BIO INC111.46%1.46%1.46%Q4 2022Q4 20221
CATABASIS PHARMACEUTIC...111.19%1.19%1.19%Q2 2021Q2 20211
CYCC CYCLACEL PHARMACEUTICA...111.12%1.12%1.12%Q4 2020Q4 20201
MLND MILLENDO THERAPEUTICS INC111.08%1.08%1.08%Q4 2020Q4 20201
VISTAGEN THERAPEUTICS INC110.96%0.96%0.96%Q3 2023Q3 20231
RAYZEBIO INC110.75%0.75%0.75%Q3 2023Q3 20231
APOGEE THERAPEUTICS INC110.62%0.62%0.62%Q3 2023Q3 20231
ASTRIA THERAPEUTICS INC110.56%0.56%0.56%Q3 2021Q3 20211
ESPR ESPERION THERAPEUTICS ...110.50%0.50%0.50%Q3 2022Q3 20221
TERN TERNS PHARMACEUTICALS INC110.20%0.20%0.20%Q3 2022Q3 20221
AEGLEA BIOTHERAPEUTICS...110.17%0.17%0.17%Q3 2023Q3 20231
AGLE AEGLEA BIOTHERAPEUTICS...110.15%0.15%0.15%Q2 2023Q2 20231
 Download

The securities at the top of the list , including XENON PHARMACEUTICALS INC, COGENT BIOSCIENCES INC, and VIRIDIAN THERAPEUTICS INC, are the highest-conviction holdings of COMMODORE CAPITAL LP.

The conviction is calculated by counting the number of quarters a security has been reported by COMMODORE CAPITAL LP. The higher the number, the higher the conviction and longer the holding period.

This page lists all the securities that COMMODORE CAPITAL LP owns currently or has owned in the past.